Výsledky vyhledávání - "Drug Monitoring - methods"

  1. 1

    Differential Effects of FODMAPs (Fermentable Oligo-, Di-, Mono-Saccharides and Polyols) on Small and Large Intestinal Contents in Healthy Subjects Shown by MRI Autor Murray, Kathryn, Wilkinson-Smith, Victoria, Hoad, Caroline, Costigan, Carolyn, Cox, Eleanor, Lam, Ching, Marciani, Luca, Gowland, Penny, Spiller, Robin C

    ISSN: 0002-9270, 1572-0241, 1572-0241
    Vydáno: United States Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins 01.01.2014
    “…The objective of this study was to investigate whether ingestion of fructose and fructans (such as inulin) can exacerbate irritable bowel syndrome (IBS)…”
    Získat plný text
    Journal Article
  2. 2
  3. 3

    Pharmacokinetics, Safety, and Tolerability of Tezepelumab (AMG 157) in Healthy and Atopic Dermatitis Adult Subjects Autor Parnes, Jane R., Sullivan, John T., Chen, Li, Dias, Clapton

    ISSN: 0009-9236, 1532-6535, 1532-6535
    Vydáno: United States 01.08.2019
    “…‐ascending doses in two randomized, double‐blind, placebo‐controlled phase I studies. Healthy and atopic dermatitis subjects were enrolled in the single…”
    Získat plný text
    Journal Article
  4. 4
  5. 5
  6. 6

    The monitoring of vancomycin: a systematic review and meta-analyses of area under the concentration-time curve-guided dosing and trough-guided dosing Autor Tsutsuura, Moeko, Moriyama, Hiromu, Kojima, Nana, Mizukami, Yuki, Tashiro, Sho, Osa, Sumika, Enoki, Yuki, Taguchi, Kazuaki, Oda, Kazutaka, Fujii, Satoshi, Takahashi, Yoshiko, Hamada, Yukihiro, Kimura, Toshimi, Takesue, Yoshio, Matsumoto, Kazuaki

    ISSN: 1471-2334, 1471-2334
    Vydáno: London BioMed Central 06.02.2021
    Vydáno v BMC infectious diseases (06.02.2021)
    “…Background This systematic review and meta-analysis explored the relationship between vancomycin (VCM) monitoring strategies and VCM effectiveness and safety…”
    Získat plný text
    Journal Article
  7. 7

    Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis Autor Kraus, V.B., Burnett, B., Coindreau, J., Cottrell, S., Eyre, D., Gendreau, M., Gardiner, J., Garnero, P., Hardin, J., Henrotin, Y., Heinegård, D., Ko, A., Lohmander, L.S., Matthews, G., Menetski, J., Moskowitz, R., Persiani, S., Poole, A.R., Rousseau, J.-C., Todman, M.

    ISSN: 1063-4584, 1522-9653, 1522-9653
    Vydáno: England Elsevier Ltd 2011
    Vydáno v Osteoarthritis and cartilage (2011)
    “…Osteoarthritis (OA) is a chronic and slowly progressive disease for which biomarkers may be able to provide a more rapid indication of therapeutic responses to…”
    Získat plný text
    Journal Article
  8. 8

    Accuracy of the Eosinophilic Esophagitis Endoscopic Reference Score in Diagnosis and Determining Response to Treatment Autor Dellon, Evan S, Cotton, Cary C, Gebhart, Jessica H, Higgins, Leana L, Beitia, RoseMary, Woosley, John T, Shaheen, Nicholas J

    ISSN: 1542-7714
    Vydáno: United States 01.01.2016
    “…); 144 subjects without EoE were included as control subjects. EREFS scores were compared between cases and control subjects…”
    Zjistit podrobnosti o přístupu
    Journal Article
  9. 9

    Improved Long-term Outcomes of Patients With Inflammatory Bowel Disease Receiving Proactive Compared With Reactive Monitoring of Serum Concentrations of Infliximab Autor Papamichael, Konstantinos, Chachu, Karen A, Vajravelu, Ravy K, Vaughn, Byron P, Ni, Josephine, Osterman, Mark T, Cheifetz, Adam S

    ISSN: 1542-7714, 1542-7714
    Vydáno: United States 01.10.2017
    “…) receiving infliximab maintenance therapy. The subjects received proactive (n = 130) or reactive (n = 134) drug monitoring, based on measurements of first infliximab concentration and antibodies to infliximab, from September…”
    Zjistit podrobnosti o přístupu
    Journal Article
  10. 10

    Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study Autor Murakami, Kazunari, Sakurai, Yuuichi, Shiino, Madoka, Funao, Nobuo, Nishimura, Akira, Asaka, Masahiro

    ISSN: 0017-5749, 1468-3288
    Vydáno: England BMJ Publishing Group LTD 01.09.2016
    Vydáno v Gut (01.09.2016)
    “… (with amoxicillin 750 mg and metronidazole 250 mg) as an open-label treatment.ResultsOf the 650 subjects randomly allocated to either first-line triple therapy, 641 subjects completed first-line therapy and 50…”
    Získat plný text
    Journal Article
  11. 11

    Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability Autor Szulc, P., Naylor, K., Hoyle, N. R., Eastell, R., Leary, E. T.

    ISSN: 0937-941X, 1433-2965, 1433-2965
    Vydáno: London Springer London 01.09.2017
    Vydáno v Osteoporosis international (01.09.2017)
    “…Summary The National Bone Health Alliance (NBHA) recommends standardized sample handling and patient preparation for C-terminal telopeptide of type I collagen…”
    Získat plný text
    Journal Article
  12. 12

    Clinical Outcomes and Plasma Concentrations of Baloxavir Marboxil and Favipiravir in COVID-19 Patients: An Exploratory Randomized, Controlled Trial Autor Lou, Yan, Liu, Lin, Yao, Hangping, Hu, Xingjiang, Su, Junwei, Xu, Kaijin, Luo, Rui, Yang, Xi, He, Lingjuan, Lu, Xiaoyang, Zhao, Qingwei, Liang, Tingbo, Qiu, Yunqing

    ISSN: 0928-0987, 1879-0720, 1879-0720
    Vydáno: Netherlands Elsevier B.V 01.02.2021
    “…•An exploratory randomized, controlled trial of baloxavir marboxil and favipiravir in COVID-19 patients were conducted.•The free drug concentrations of…”
    Získat plný text
    Journal Article
  13. 13

    Single-dose ciraparantag safely and completely reverses anticoagulant effects of edoxaban Autor Ansell, Jack E., Bakhru, Sasha H., Laulicht, Bryan E., Steiner, Solomon S., Grosso, Michael A., Brown, Karen, Dishy, Victor, Lanz, Hans J., Mercuri, Michele F., Noveck, Robert J., Costin, James C.

    ISSN: 0340-6245, 2567-689X, 2567-689X
    Vydáno: Germany Schattauer GmbH 01.02.2017
    Vydáno v Thrombosis and haemostasis (01.02.2017)
    “…) alone and following a 60 mg dose of the FXa inhibitor edoxaban. Escalating, single IV doses of ciraparantag were administered alone and following a 60 mg oral dose of edoxaban in a double-blind, placebo-controlled fashion to healthy subjects…”
    Získat plný text
    Journal Article
  14. 14
  15. 15

    Comparison of prasugrel and ticagrelor loading doses in ST-segment elevation myocardial infarction patients: RAPID (Rapid Activity of Platelet Inhibitor Drugs) primary PCI study Autor Parodi, Guido, Valenti, Renato, Bellandi, Benedetta, Migliorini, Angela, Marcucci, Rossella, Comito, Vincenzo, Carrabba, Nazario, Santini, Alberto, Gensini, Gian Franco, Abbate, Rosanna, Antoniucci, David

    ISSN: 1558-3597, 1558-3597
    Vydáno: United States 16.04.2013
    “…). However, the pharmacodynamic measurements after prasugrel and ticagrelor LD have been provided by assessing only healthy volunteers or subjects with stable coronary artery disease…”
    Zjistit podrobnosti o přístupu
    Journal Article
  16. 16

    Accurate detection of outliers and subpopulations with Pmetrics, a nonparametric and parametric pharmacometric modeling and simulation package for R Autor Neely, Michael N, van Guilder, Michael G, Yamada, Walter M, Schumitzky, Alan, Jelliffe, Roger W

    ISSN: 1536-3694, 1536-3694
    Vydáno: United States 01.08.2012
    Vydáno v Therapeutic drug monitoring (01.08.2012)
    “…Nonparametric population modeling algorithms have a theoretical superiority over parametric methods to detect pharmacokinetic and pharmacodynamic subgroups and…”
    Zjistit podrobnosti o přístupu
    Journal Article
  17. 17
  18. 18

    Impact of apixaban on routine and specific coagulation assays: a practical laboratory guide Autor Douxfils, Jonathan, Chatelain, Christian, Chatelain, Bernard, Dogné, Jean-Michel, Mullier, François

    ISSN: 0340-6245, 2567-689X, 2567-689X
    Vydáno: Germany 01.08.2013
    Vydáno v Thrombosis and haemostasis (01.08.2013)
    “…Apixaban does not require monitoring nor frequent dose adjustment. However, searching for the optimal dose for the individual patient may be useful in some…”
    Zjistit podrobnosti o přístupu
    Journal Article
  19. 19

    Effects of repeated oral doses of ketoconazole on a sequential ascending single oral dose of fedratinib in healthy subjects Autor Ogasawara, Ken, Xu, Christine, Kanamaluru, Vanaja, Palmisano, Maria, Krishna, Gopal

    ISSN: 0344-5704, 1432-0843, 1432-0843
    Vydáno: Berlin/Heidelberg Springer Berlin Heidelberg 01.05.2020
    Vydáno v Cancer chemotherapy and pharmacology (01.05.2020)
    “… The primary objective of this study was to evaluate the effects of 14-day repeated 200 mg twice daily (BID) oral doses of a strong CYP3A4 inhibitor, ketoconazole, on a sequential ascending single oral dose of fedratinib in healthy male subjects…”
    Získat plný text
    Journal Article
  20. 20

    Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients Autor Gallagher, A M, Setakis, E, Plumb, J M, Clemens, A, van Staa, T-P

    ISSN: 0340-6245, 2567-689X, 2567-689X
    Vydáno: Germany 01.11.2011
    Vydáno v Thrombosis and haemostasis (01.11.2011)
    “…Atrial fibrillation (AF) carries an increased risk of ischaemic stroke, and oral anticoagulation with warfarin can reduce this risk. The objective of this…”
    Zjistit podrobnosti o přístupu
    Journal Article